Paradoxical effects of opioid antagonist naloxone on SSRI-induced analgesia and tolerance in mice

Pharmacology

Volumn 69, Issue 3, 2003, Pages 115-122

  Singh, Vijay Pal ^a   Patil, Chandrashekhar S ^b   Jain, Naveen K ^a   Singh, Amarjit ^a   Kulkarni, Shrinivas K ^b  

^a Panacea Biotec Ltd   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Antinociception; Opioids; Selective serotonin reuptake inhibitors; Tolerance

Indexed keywords

ACETIC ACID; CITALOPRAM; FLUOXETINE; NALOXONE; OPIATE ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WRITHING TEST;

ANALGESICS; ANIMALS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG TOLERANCE; FLUOXETINE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SPINAL; MICE; NALOXONE; NARCOTIC ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0141649469     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072662     Document Type: Article

References (30)

1. Couch JR, Zieger DK, Hassanien R: Amitryptyline in the prophylaxis. Arch Neurol (Chic) 1976;26:121-127.
2. Fairbanks CV, Wilcox GL: Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J Pharmacol Ther Sci 1999;288:1107-1116.
3. Lance JN, Curran DA: Treatment of chronic tension headache. Lancet 1964;i:1236-1239.
4. Diamond S, Balter BJ: Chronic tension headache treated with amitryptyline: A double blind clinical study. Headache 1971;11:110-116.
5. Taub A: Relief of post-therapeutic neuralgia with psychotropic drugs. J Neurosurg 1973;39:235-239.
6. McQuary H, Tramer M: A systemic review of antidepressants in neuropathic pain. Br Med J 1995;311:1047-1052.
7. Turkington RW: Depression masquerading as diabetic neuropathy. J Mer Med Ass 1980;243:1147-1150.
8. Harris M: Psychogenic aspects of facial pain. Br Dent J 1974;136:199-202.
9. Brooke RI: Atypical odontalgia: A report of twenty-two cases. Oral Surg 1980;49:196-199.
10. Menecier P, Menecier-Ossia L, Bern P: Fluoxetine dependence and tolerance: A propos of a case. Encephale 1997;23:400-401.
11. Bjork JM, Gayton O, Ratt N, Swann AC, Dafny N: Behavioral tolerance to and withdrawal from multiple fluoxetine administration. Int J Neurosci 1998;93:163-179.
12. Singh VP, Jain NK, Kulkarni SK: On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 2001; 915:218-226.
13. Gorlitz BD, Frey HH: Central monoamines and nociceptive action. Eur J Pharmacol 1972;20:171-180.
14. Brase DA: Roles of serotonin and γ-amino butyric acid in opioid effect. Adv Biochem Psycho Pharmacol 1979:20:409-428.
15. Aurebach S, Fornal C, Jacob BL: Response of serotonin containing neurons in nucleus raphe magnus to morphine, noxious stimuli and periaqueductal gray stimulation in freely moving cats. Exp Neurol 1985;88:609-628.
16. Feva GV: Long term treatment with antidepressant drugs: The spectacular achievement of propaganda. Psychosom 2002;71:127-132.
17. Gracely RN, McGrath R, Dubner R: Narcotic analgesia: Fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 1979;203:1261-1263.
18. Reichenberg K, Gaillard-Plaza G, Montastruc JL: Influence of naloxone on the antinociceptive effect of some antidepressant drugs. Arch Int Pharmacodyn Ther 1985:275:78-85.
19. Chen GG, Chalazonitis A, Shen KF, Crain SM: Inhibition of c-AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in disassociated cell cultures. Brain Res 1988;462:372-377.
20. Shen KF, Crain SM: Ultra-low dose of naltrexone or etrophine increases morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res 1974;754:176-190.
21. Powell KJ, Abul Husan NS, Jhamandas A, Olmstead C, Beninger JR, Jhamandas K: Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance and reward in rats. J Pharmacol Exp Ther 2002;300:588-596.
22. Crain SM, Shen KF: Acute thermal hyperalgesia elicited by low dose of morphine in normal mice is blocked but ultra-low dose of naltrexone, unmasking potent opioid analgesia. Brain Res 2001;888:75-78.
23. Crain SM, Shen KF: Ultra low concentration of naloxone selectively antagonize excitability effect of morphine on sensory neurons, thereby increasing its antinociceptive effect and attenuating tolerance and dependence during chronic cotreatment. Proc Natl Acad Sci USA 1995;92:10540-10544.
24. Hylden JLK, Wilcox GL: Intrathecal morphine administration in mice: A new technique. Eur J Pharmacol 1980;67:313-316.
25. i proteins. J Pharmacol Exp Ther 1999;288:98-106.
26. 1A receptor responsivity in obsessive-compulsive disorder. Psychopharmacology 1991;105:415-420.
27. o proteins and on neuroendocrine response to a 5-HT agonist. J Pharmacol Exp Ther 1994;279:1035-1042.
28. Gandariae JM, Echevasria E, Acebes I, Abecia LC, Casis O, Casis L: Effect of fluoxetine administration on mu-opioid receptor immuno-staining in the rat forebrain. Brain Res 1999;817:236-240.
29. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowed BF: Oligomerization of mu and delta receptors: Generation of novel functional properties. J Biol Chem 2001;275:26128-26135.
30. Gomes I, Jordan BA, Gupta A, Tapaidz N, Nagy V, Devi LA: Heterodimerization of mu and delta receptors: A role in opiate synergy. J Neurosci 2000;20:RC110.